Parkinson’s disease: FDA approves Nourianz as an add-on treatment
The U.S. Food and Drug Administration today approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing “off” More...
Huntington’s disease with George Yohrling, PhD
Huntington’s disease (HD) is a progressive brain disorder that deteriorates a person’s physical and mental abilities. It primarily affects adults; however, there is a form that affects children, albeit less More...
NFL Players’ $1 Billion Concussion Settlement Put on Hold by Appeal
A proposed $1 billion settlement to the NFL players’ concussion lawsuit is headed to the Supreme Court to answer questions about distribution of the settlement posed by one former player’s family. The family More...
Marshall University scientists develop a new approach for Parkinson’s disease therapy
Last year, Dr. Elmer Price, a professor of biological sciences at Marshall University, was awarded a three-year, $350,000 research grant from the National Science Foundation. The grant funds his research into understanding More...
Scripps Research Institute: Tacrolimus and astemizole may be effective in treating human prion disease
Prion diseases or transmissible spongiform encephalopathies (TSEs) are a family of rare progressive neurodegenerative disorders that affect both humans and animals, according to the CDC. Contracting this disease More...
